Molecular interactions of SHP1 and SHP2 in IL-3-signalling

被引:26
|
作者
Wheadon, H [1 ]
Paling, NRD [1 ]
Welham, MJ [1 ]
机构
[1] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England
关键词
SHP1; SlIP2; IL-3; Gab-2; PIR-B; receptor; substrate-trapping;
D O I
10.1016/S0898-6568(01)00241-8
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
SHP1 and SHP2 tyrosine phosphatases have both been implicated in signalling pathways downstream of the interleukin-3 (IL-3) reccptor. We have investigated the cc-association of SHP1 and SHP2 with tyrosine-phosphorylated proteins in IL-3-dependent BaF/3 cells. We demonstrate that both SHP1 and SHP2 associate with Aic2A (beta chain of the IL-3 receptor), Gab2 and the paired inhibitory receptor B (PIR-B). The individual SH2 domains of SHP2 can independently bind Gab2, potentially important for the adapter function of SHP2. Association of both phosphatases with Aic2A and Gab2 increases upon IL-3 treatment. Recruitment of SHP1 to PIR-B also increases in response to IL-3, suggesting a functional link between inhibitory and cytokine receptor signalling. Aic2A is a rapid target for dephosphorylation following IL-3 stimulation and substrate-trapping versions of both phosphatases identify Aic2A and Gab2 as substrates for SHP1 and SHP2. These studies suggest that SH2-domain interactions are important for targetting these phosphatases to their substrates. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:219 / 229
页数:11
相关论文
共 50 条
  • [1] Molecular features underlying differential SHP1/SHP2 binding of immune checkpoint receptors
    Xu, Xiaozheng
    Masubuchi, Takeya
    Cai, Qixu
    Zhao, Yunlong
    Hui, Enfu
    ELIFE, 2021, 10
  • [2] Severe macrothrombocytopenia and abnormal megakaryocyte development in mice lacking Shp1 and Shp2
    Mazharian, A.
    Wang, Y-J
    Mori, J.
    Heising, S.
    Neel, B. G.
    Watson, S. P.
    Senis, Y. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 33 - 33
  • [3] Tyrosine phosphatases Shp1 and Shp2 have unique and opposing roles in oligodendrocyte development
    Kuo, Emory
    Park, Daniel K.
    Tzvetanova, Iva D.
    Leiton, Cindy V.
    Cho, Brian S.
    Colognato, Holly
    JOURNAL OF NEUROCHEMISTRY, 2010, 113 (01) : 200 - 212
  • [4] β-chemokine receptor CCR5 signals through SHP1, SHP2, and Syk
    Ganju, RK
    Brubaker, SA
    Chernock, RD
    Avraham, S
    Groopman, JE
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (23) : 17263 - 17268
  • [5] Inhibition of SHP2 and SHP1 Protein Tyrosine Phosphatase Activity by Chemically Induced Dimerization
    Buck, Sara J. S.
    Plaman, Bailey A.
    Bishop, Anthony C.
    ACS OMEGA, 2022, 7 (16): : 14180 - 14188
  • [6] Exploration of T cell immune responses by expression of a dominant-negative SHP1 and SHP2
    Taylor, Julia
    Bulek, Anna
    Gannon, Isaac
    Robson, Mathew
    Kokalaki, Evangelia
    Grothier, Thomas
    McKenzie, Callum
    El-Kholy, Mohamed
    Stavrou, Maria
    Traynor-White, Charlotte
    Lim, Wen Chean
    Panagiotou, Panagiota
    Srivastava, Saket
    Baldan, Vania
    Sillibourne, James
    Ferrari, Mathieu
    Pule, Martin
    Thomas, Simon
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [7] Morphological analysis of female gametophyte development in the bel1 stk shp1 shp2 mutant
    Raffaella, B.
    Vittoria, B.
    Colombo, L.
    PLANT BIOSYSTEMS, 2008, 142 (03): : 643 - 649
  • [8] Destabilization of the SHP2 and SHP1 protein tyrosine phosphatase domains by a non-conserved "backdoor" cysteine
    Yarnall, Matthew T. N.
    Kim, Sean H.
    Korntner, Samuel
    Bishop, Anthony C.
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2022, 32
  • [9] Cooperative regulation of Stat3 signaling by TC-PTP, SHP1, and SHP2 in keratinocytes following UVB irradiation
    Kim, Dae Joon
    Tremblay, Michel L.
    DiGiovanni, John
    CANCER RESEARCH, 2010, 70
  • [10] SHP1 and the airways
    Buckland, J
    NATURE REVIEWS IMMUNOLOGY, 2003, 3 (02) : 94 - 94